tranScrip
Karen Nugent has a wealth of experience in the pharmaceutical and healthcare industry. Karen most recently held the position of Senior VP, Head of Project Delivery at tranScrip starting from July 2020. Before that, they served as VP, Clinical Operations at Summit Therapeutics from June 2017 to April 2020. Prior to these roles, Karen worked at GE Healthcare as a Program Lead (Contract) from November 2016 to June 2017, and at Shield Therapeutics as VP, Clinical Development from December 2015 to June 2016. From November 2009 to December 2015, they held the position of Director, Clinical Operations Sciences at Biogen, and prior to that was a Senior Clinical Trial Manager at Biogen from November 2007 to November 2009. Karen also has experience as a Snr Clinical Trial Manager at Pfizer, Pharmacia from 2005 to 2007, a Snr Clinical Scientist at Pharmacia from 2001 to 2003, and a Clinical Program Manager at Napp from 2000 to 2001. Karen began their career as a Senior Clinical Research Associate at Covance from May 1994 to January 2000.
Karen Nugent earned their Master of Science (MSc) degree from the University of Leeds in 1995.
This person is not in any offices
tranScrip
tranScrip is a leading contract drug development organisation which supports pharma and biotech companies in the development and lifecycle of medicines. We bring innovative solutions to clients’ global drug development needs. From translational medicine through to registration and post licencing, we deliver both strategic leadership and operational execution of development programmes, covering clinical, regulatory, drug safety, and commercial elements. Our teams of physicians, scientists and regulatory experts, help clients select the most promising drug candidates and bring them to the market. We guide our clients through their decision making from first in man studies to proof of concept and pivotal trials, regulatory submissions and product launches. In the last decade, tranScrip has supported over 250 clients and has been integral to many development programmes and regulatory submissions, bringing products to the market each year across a wide range of therapeutic areas.